NO985214L - Inhibitorer for produksjon av s-CD23 og sekresjon av TNF - Google Patents

Inhibitorer for produksjon av s-CD23 og sekresjon av TNF

Info

Publication number
NO985214L
NO985214L NO985214A NO985214A NO985214L NO 985214 L NO985214 L NO 985214L NO 985214 A NO985214 A NO 985214A NO 985214 A NO985214 A NO 985214A NO 985214 L NO985214 L NO 985214L
Authority
NO
Norway
Prior art keywords
alkyl
aryl
alkenyl
hydroxy
carboxy
Prior art date
Application number
NO985214A
Other languages
English (en)
Other versions
NO985214D0 (no
Inventor
Stuart Bailey
Derek Richard Buckle
Andrew Faller
David Glynn Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO985214D0 publication Critical patent/NO985214D0/no
Publication of NO985214L publication Critical patent/NO985214L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Forbindelser med formel (I): HON NHR3 ROR' (I) hvor: R er hydroksy, hydrogen, alkyl, alkenyl, alkynyl eller aryl; R"1 er arylmetyl eller heterocyklylmetyl; R2 er alkyl, alkenyl, aryl, cykloalkyl eller cykloalkenyl; og R3 er hydrogen, alkyl, alkenyl, alkynyl eller aryl; med det forbehold at; hvis R1 er fenylmetyl eller naftylmetyl, hvor fenyl- eller naftylgruppen er usubstituert eller substituert med opptil fem substituenter valgt fra gruppen bestående av halogen, (Ci_6)alkyl, aryl(Ci_6)alkyl, (Ci_6)alkoksy, (C-).6)alkoksy(c1-6)alky1- halogen(Ci_6)alkyl, hydroksy, nitro, amino, mono- og di-A/-(C<|-6)alkylamino, acylamino, acyloksy, karboksy, karboksy salter, karboksyestere, karbamoyl, mono- og di-A/-(Ci_6)alkylkarbamoyl, (Ci-6)alkoksykarbonyl, aryloksykarbonyl, ureido, guanidino, sulfonylamino, aminosulfonyl, (Ci_6)alkyltio, (Ci_6)alkylsulfinyl (C-j-6)alkylsulfonyl, heterocyklyl, heterocyklyl(Ci_6)alkyl og en (Cs-5)alkylenkjede som binder sammen to ringkarbonatomer i nabostilling under dannelse av en karbocyklisk ring; da R er hydroksy; er nyttige ved behandling av lidelser betinget av s-CD23.
NO985214A 1996-05-10 1998-11-09 Inhibitorer for produksjon av s-CD23 og sekresjon av TNF NO985214L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9609794.4A GB9609794D0 (en) 1996-05-10 1996-05-10 Novel compounds
PCT/EP1997/002433 WO1997043249A1 (en) 1996-05-10 1997-05-06 INHIBITORS OF THE PRODUCTION OF s-CD23 AND THE SECRETION OF TNF

Publications (2)

Publication Number Publication Date
NO985214D0 NO985214D0 (no) 1998-11-09
NO985214L true NO985214L (no) 1998-12-01

Family

ID=10793494

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985214A NO985214L (no) 1996-05-10 1998-11-09 Inhibitorer for produksjon av s-CD23 og sekresjon av TNF

Country Status (21)

Country Link
US (1) US6235753B1 (no)
EP (1) EP0918747B1 (no)
JP (1) JP2000510473A (no)
KR (1) KR20000010892A (no)
AR (1) AR007060A1 (no)
AT (1) ATE246673T1 (no)
AU (1) AU2897397A (no)
BR (1) BR9709450A (no)
CA (1) CA2253590A1 (no)
CO (1) CO4990945A1 (no)
CZ (1) CZ363198A3 (no)
DE (1) DE69723984T2 (no)
ES (1) ES2205218T3 (no)
GB (1) GB9609794D0 (no)
IL (1) IL126860A0 (no)
NO (1) NO985214L (no)
NZ (1) NZ332628A (no)
PL (1) PL329855A1 (no)
TR (1) TR199802271T2 (no)
WO (1) WO1997043249A1 (no)
ZA (1) ZA973964B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020082200A1 (en) * 1994-07-13 2002-06-27 Smithkline Beecham P.1.C. Use of inhibitors of human S-CD23
US6548084B2 (en) 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
AUPO721997A0 (en) * 1997-06-06 1997-07-03 Queensland Institute Of Medical Research, The Anticancer compounds
EP1030851B1 (en) * 1997-11-12 2005-01-12 Darwin Discovery Limited Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
GB9813451D0 (en) * 1998-06-22 1998-08-19 Smithkline Beecham Plc Novel compounds
GB9922825D0 (en) * 1999-09-25 1999-11-24 Smithkline Beecham Biolog Medical use
US6541661B1 (en) 1999-11-23 2003-04-01 Methylgene, Inc. Inhibitors of histone deacetylase
GB9930754D0 (en) * 1999-12-29 2000-02-16 Smithkline Beecham Plc Novel compounds
US7652036B2 (en) 2003-02-25 2010-01-26 Topotarget Uk Limited Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitors
GB0818907D0 (en) * 2008-10-15 2008-11-19 Isis Innovation Histone lysine demethylase inhibitors
SG176010A1 (en) 2009-05-28 2011-12-29 Novartis Ag Substituted aminobutyric derivatives as neprilysin inhibitors
AU2010251967B9 (en) * 2009-05-28 2014-04-03 Novartis Ag Substituted aminopropionic derivatives as neprilysin inhibitors
US8945575B2 (en) 2009-12-01 2015-02-03 Trustees Of Boston University Treatment of IgE-mediated disease
JP6295277B2 (ja) 2013-02-14 2018-03-14 ノバルティス アーゲー Ｎｅｐ（中性エンドペプチダーゼ）阻害剤としての置換ビスフェニルブタン酸ホスホン酸誘導体
CA2900226A1 (en) 2013-02-14 2014-08-21 Novartis Ag Substituted bisphenyl butanoic acid derivatives as nep inhibitors with improved in vivo efficacy
CA2963875A1 (en) * 2014-11-19 2016-05-26 Actelion Pharmaceuticals Ltd Antibacterial benzothiazole derivatives
CN113194954A (zh) 2018-10-04 2021-07-30 国家医疗保健研究所 用于治疗角皮病的egfr抑制剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9215665D0 (en) * 1992-07-23 1992-09-09 British Bio Technology Compounds
ES2144819T3 (es) * 1994-01-20 2000-06-16 British Biotech Pharm L-terc-leucina-2-piridilamida.
GB9414157D0 (en) * 1994-07-13 1994-08-31 Smithkline Beecham Plc Medical use
US5562917A (en) 1994-12-23 1996-10-08 Pentech Pharmaceuticals, Inc. Transdermal administration of apomorphine
DE19506492C2 (de) 1995-02-24 2003-05-08 Focke & Co Einrichtung zum Speichern von Zigaretten oder dergleichen
US5570079A (en) 1995-04-24 1996-10-29 Dockery; Devan Home security system for detecting an intrusion into a monitored area by an infrared detector

Also Published As

Publication number Publication date
EP0918747A1 (en) 1999-06-02
PL329855A1 (en) 1999-04-12
JP2000510473A (ja) 2000-08-15
NO985214D0 (no) 1998-11-09
CZ363198A3 (cs) 1999-06-16
WO1997043249A1 (en) 1997-11-20
CO4990945A1 (es) 2000-12-26
BR9709450A (pt) 1999-08-10
US6235753B1 (en) 2001-05-22
TR199802271T2 (xx) 2000-08-21
KR20000010892A (ko) 2000-02-25
AR007060A1 (es) 1999-10-13
AU2897397A (en) 1997-12-05
ES2205218T3 (es) 2004-05-01
ZA973964B (en) 1998-11-09
DE69723984D1 (de) 2003-09-11
IL126860A0 (en) 1999-09-22
CA2253590A1 (en) 1997-11-20
DE69723984T2 (de) 2004-06-09
GB9609794D0 (en) 1996-07-17
EP0918747B1 (en) 2003-08-06
ATE246673T1 (de) 2003-08-15
NZ332628A (en) 2000-06-23

Similar Documents

Publication Publication Date Title
NO985214L (no) Inhibitorer for produksjon av s-CD23 og sekresjon av TNF
PT729455E (pt) Arilpiperazinas derivadas de indol como ligados para os receptores 5ht1-like, 5ht1b e 5ht1d
MX9203249A (es) Derivados del acido bencimidazolin-2-oxo-1-carboxilico y composiciones farmaceuticas que los contienen.
IL103657A0 (en) Acyclic ethylenediamine derivatives
NZ511394A (en) N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
CA2229000A1 (en) 1-biphenylimidazole derivatives, their preparation and their therapeutic use
MX9603506A (es) Compuestos oxazol aromaticos, heterociclicos y sus usos.
AU2003210203A1 (en) Aqueous dispersions consisting of polycarbodiimides
DK0711291T3 (da) N-(Piperidinyl-1-alkyl)-substituerede cyclohexancarboxylsyreamider som 5-HT1A-receptorantagonister
HUP0203787A2 (hu) Hidroxi-acetil-piperazinnal szubsztituált oxazolidinon-benzoesav-észterek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
AU5247993A (en) Antiretroviral hydrazine derivatives
GB1329491A (en) Urea derivatives and herbicidal compositions containing them
ATE113588T1 (de) Heterocyclisch substituierte alkyl- und alkenylsulfonylharnstoffe, verfahren zu ihrer herstellung und ihre verwendung als herbizide oder pflanzenwachstumsregulatoren.
ES2114676T3 (es) Derivados substituidos del acido orto-etenilfenilacetico.
AU4683193A (en) Cyanoguanidines as potassium channel blockers
AU5674894A (en) Azanoradamantanes
EP0116432A3 (en) Improvements in or relating to n-(substituted-methyl)-azetidin-2-ones
DE69416311T2 (de) Verwendung von cephem-derivaten als antimetastatische mittel
GB1151450A (en) Arylsulphonylureas and -Thioureas

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application